Reichman University Hosts Medical Conference on Brain Research and Alzheimer's
Over 1,000 medical professionals are expected to attend the fourth annual L'maanchem conference, which will feature presentations on brain implants, neurology, and addiction medicine.
By Amir Shah ·

The fourth annual L'maanchem medical conference is scheduled to take place on December 3 at Reichman University in Herzliya. Organizers anticipate a large turnout, expecting more than 1,000 participants from Israel and other countries. The attendee list is expected to include physicians, researchers, and hospital administrators who will gather to discuss recent advancements in several key areas of medicine.
A central focus of the event will be research into Alzheimer's disease and the complex interactions between the immune system and the brain. Prof. Michal Schwartz, a neuroimmunologist at the Weizmann Institute of Science and a recipient of the Israel Prize, will lead this discussion. She is scheduled to explore how immune responses within the brain might offer new insights for treating Alzheimer's.
In addition to Alzheimer's, the conference will address the neurological underpinnings of mental health conditions. Prof. Rony Paz, a neuroscientist at the Weizmann Institute, will present on how the brain handles learning, memory, and emotional processing. His talk will specifically examine the relationship between these cognitive processes and disorders such as anxiety and post-traumatic stress.
The program also highlights significant developments in brain-computer interfaces. Prof. Marc Slutzky of Northwestern University will discuss technology that translates brain signals into commands for external devices. His presentation will focus on research aimed at helping individuals with neurological injuries to communicate or regain movement capabilities.
Representatives from the private sector will also share their work. Rotem Kopel, the CEO of ABILITY Neurotech, is set to present an investigational brain implant. This device uses light to transmit data wirelessly through the skin. Organizers noted that the implant is currently in the research phase and is not yet available for commercial use.
A panel discussion will address the broader landscape of neurological care. Prof. Eitan Auriel, who heads the neurology department at Beilinson Hospital, and Prof. Sagi Harnof, who leads the neurosurgery department at the same institution, will participate. They will discuss various technologies used for diagnosing and treating neurological disorders, including methods designed to alter nerve activity.
The event will also honor physician Miriam Adelson for her contributions to addiction medicine. She will join Prof. Eli Sprecher, CEO of Tel Aviv Sourasky Medical Center, and Dr. Michal Mekel, director-general of Rambam Health Care Campus, for a discussion. The conversation will cover Adelson's career and the treatment centers she established with her late husband, Sheldon Adelson.
University leadership will play a prominent role in the proceedings. Uriel Reichman, the founding president and current board chair of Reichman University, will host the conference. Other expected attendees include University President Boaz Ganor and Arnon Afek, the founding dean of the Dina Recanati School of Medicine.
The conference is organized by L'maanchem, a foundation that was founded and is chaired by Yossi Erblich. Beyond hosting this annual medical event, the organization provides free medical guidance and assists patients in navigating the complexities of the Israeli health system.






